Probiotics / prebiotics / antibiotics Tacrolimus concentration to dose ratio in solid organ transplant patients treated with
fecal microbiota transplantation for recurrent Clostridium difficile infection.
Oral, capsulized, frozen
fecal microbiota transplantation for relapsing Clostridium difficile infection.
Not exact matches
«So far, it has not been sufficiently tested whether and how successful
fecal transplantation is
for the permanent settlement of
microbiota from a healthy donor to a patient,» said Alexander Loy of the Department of Microbiology and Ecosystem Research, University of Vienna.
«
Fecal microbiota transplantation has been very successful
for many patients with C. difficile infections, but we've never known why.
In a retrospective, multicenter, longitudinal observational study, the response rates to
fecal microbiota transplantation as a treatment
for recurrent C. difficile infection were determined a 30 and 90 days, and adverse events were registered.
The authors call
for more uniform documentation of the clinical efficacy and safety of
fecal microbiota transplantation.
Analysis of Treatment Outcomes
for Recurrent Clostridium difficile Infections and
Fecal Microbiota Transplantation in a Pediatric Hospital
Fecal Microbiota Transplantation in Inflammatory Bowel Disease - a Primer
for the Internists — Gaurav Syal — The American Journal of Medicine
Analysis of Treatment Outcomes
for Recurrent Clostridium difficile Infections and
Fecal Microbiota Transplantation in a Pediatric Hospital — Aileen Aldrich — The Pediatric Infectious Disease Journal
For this subgroup of patients, a promising new treatment called
Fecal Microbiota Transplantation (FMT) brings hope.
The first study of the social and ethical issues associated with a provocative approach to treatment
for ulcerative colitis has found that the majority of potential patients are eager
for what is now called «
fecal microbiota transplantation» to become available, although many have concerns about donor selection, screening, and methods of delivery.
June 2, 2011 Patients with bowel disease eager to test «
fecal» therapy The first study of the social and ethical issues associated with a provocative approach to treatment
for ulcerative colitis has found that the majority of potential patients are eager
for what is now called «
fecal microbiota transplantation» to become available, although many have concerns about donor selection, screening, and methods of delivery.
Our
Fecal Microbiota Transplantation (FMT) residential programs include fecal transplants for the treatment of Clostridium Difficile infection (C.Diff) and a comprehensive educational program for many other conditions including obesity, Crohn's disease, ulcerative colitis, anxiety, depression and schizophr
Fecal Microbiota Transplantation (FMT) residential programs include
fecal transplants for the treatment of Clostridium Difficile infection (C.Diff) and a comprehensive educational program for many other conditions including obesity, Crohn's disease, ulcerative colitis, anxiety, depression and schizophr
fecal transplants
for the treatment of Clostridium Difficile infection (C.Diff) and a comprehensive educational program
for many other conditions including obesity, Crohn's disease, ulcerative colitis, anxiety, depression and schizophrenia.
The 5 - day program
for Fecal Microbiota Transplantation (FMT) includes two colonics, three infusions (transplants) of a fresh specimen and a chamomile enema.